With increasing interest in clinical research as a care option given limited access to the latest treatments, we are continuing to expand our network in this rapidly developing market.
“Having worked with other generic CROs in the past for the last 15 years, our first experience with Ora was a problem solver. Most miscommunication and lack of understanding of the conditions that we have with other CROs, do not happen with ORA, being an Ophthalmology specialized CRO with hands on and direct contact with sites at all times. If I would decide which CRO to work with, my choice would be ORA every time.”
Patricio Schlottmann, MD
OMI, Buenos Aires